Literature DB >> 20582599

Why so late?!--delay in treatment of colorectal cancer is socially determined.

Mike Ralf Langenbach1, Stefan Sauerland, Karl-Wilhelm Kröbel, Hubert Zirngibl.   

Abstract

PURPOSE: The interval between symptom onset and therapy in patients with colorectal cancer was studied.
METHODS: One hundred twenty three patients with colorectal cancer were included. Demography data, symptoms, consultations, and tumour stage were obtained by standardized questionnaires. Risk factors for delayed treatment were analysed.
RESULTS: Eighty six patients suffered from colonic cancer. The total time between the first symptoms and therapy ranged from 13 to 442 days (mean, 148). Delay of surgical therapy was responsible for significantly higher tumour grades. Delayed start of therapy was found to be correlated to the type of cancer, socioeconomic status, marital status, and quality of first consultation (univariate analysis). On multivariate analyses, type of cancer, marital and socioeconomic status remained significantly associated with delayed treatment (all p values ≤ 0.001, r(2) = 0.50).
CONCLUSIONS: The delay in treatment of colorectal cancer depends on socioeconomic status and family background. Achieving equity in colorectal cancer detection may require consideration of high-risk subgroups.

Entities:  

Mesh:

Year:  2010        PMID: 20582599     DOI: 10.1007/s00423-010-0664-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  31 in total

1.  Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.

Authors:  M Korsgaard; L Pedersen; H T Sørensen; S Laurberg
Journal:  Colorectal Dis       Date:  2006-10       Impact factor: 3.788

2.  The colorectal carcinoma prognosis factors. Significance of diagnosis delay.

Authors:  E Gómez-Domínguez; M Trapero-Marugán; A J del Pozo; J Cantero; J P Gisbert; J Maté
Journal:  Rev Esp Enferm Dig       Date:  2006-05       Impact factor: 2.086

3.  Quality management in rectal carcinoma: what is feasible?

Authors:  Susanne Merkel; Daniela Klossek; Jonas Göhl; Thomas Papadopoulos; Werner Hohenberger; Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2009-06-02       Impact factor: 2.571

4.  Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer.

Authors:  Marianne Korsgaard; Lars Pedersen; Henrik Toft Sørensen; Søren Laurberg
Journal:  Cancer Detect Prev       Date:  2006-09-11

5.  A short diagnostic delay is more important for rectal cancer than for colonic cancer.

Authors:  G Arbman; E Nilsson; V Störgren-Fordell; R Sjödahl
Journal:  Eur J Surg       Date:  1996-11

6.  Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.

Authors:  Sun Hee Rim; Laura Seeff; Faruque Ahmed; Jessica B King; Steven S Coughlin
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

7.  Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies.

Authors:  Hermann Brenner; Michael Hoffmeister; Gerhard Brenner; Lutz Altenhofen; Ulrike Haug
Journal:  Eur J Cancer       Date:  2009-03-14       Impact factor: 9.162

8.  Causes of late diagnosis in cases of colorectal cancer seen in a district general hospital over a 2-year period.

Authors:  G J Harris; J N Simson
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

9.  Colorectal cancer: incidence, delay in diagnosis and stage of disease.

Authors:  E Robinson; J Mohilever; J Zidan; D Sapir
Journal:  Eur J Cancer Clin Oncol       Date:  1986-02

Review 10.  Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review.

Authors:  Maria Ramos; Magdalena Esteva; Elena Cabeza; Carlos Campillo; Joan Llobera; Antonio Aguiló
Journal:  Eur J Cancer       Date:  2007-10-10       Impact factor: 9.162

View more
  7 in total

Review 1.  Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.

Authors:  Christina Sinding; Rachel Warren; Donna Fitzpatrick-Lewis; Jonathan Sussman
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

Review 2.  Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.

Authors:  Charlotte J L Molenaar; Loes Janssen; Donald L van der Peet; Desmond C Winter; Rudi M H Roumen; Gerrit D Slooter
Journal:  World J Surg       Date:  2021-04-03       Impact factor: 3.352

3.  Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.

Authors:  Marcela Ewing; Peter Naredi; Chenyang Zhang; Jörgen Månsson
Journal:  Br J Gen Pract       Date:  2016-11-07       Impact factor: 5.386

4.  Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.

Authors:  Laura V Bownes; Laura L Stafman; Ilan I Maizlin; Matthew Dellinger; Kenneth W Gow; Adam B Goldin; Melanie Goldfarb; Monica Langer; Mehul V Raval; John J Doski; Jed G Nuchtern; Sanjeev A Vasudevan; Elizabeth A Beierle
Journal:  J Surg Res       Date:  2017-10-06       Impact factor: 2.192

5.  Applying Latent Class Analysis on Cancer Registry Data to Identify and Compare Health Disparity Profiles in Colorectal Cancer Surgical Treatment Delay.

Authors:  Francisco A Montiel Ishino; Emmanuel A Odame; Kevin Villalobos; Martin Whiteside; Hadii Mamudu; Faustine Williams
Journal:  J Public Health Manag Pract       Date:  2022 Mar-Apr 01

6.  Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer.

Authors:  David Weber; Laurence Amar; Daniel Gödde; Christian Prinz
Journal:  Oncotarget       Date:  2018-06-05

7.  Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease.

Authors:  Moniek van Zutphen; Anouk Geelen; Hendriek C Boshuizen; Renate M Winkels; Anne J M R Geijsen; Evertine Wesselink; Merel Snellen; Dieuwertje E Kok; Johannes H W de Wilt; Paul C van de Meeberg; Ewout A Kouwenhoven; Henk K van Halteren; Ernst J Spillenaar Bilgen; Ellen Kampman; Fränzel J B van Duijnhoven
Journal:  Support Care Cancer       Date:  2018-11-27       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.